These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression. Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519 [TBL] [Abstract][Full Text] [Related]
3. Plasmacytoid dendritic cells have a cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming. Ogata M; Ito T; Shimamoto K; Nakanishi T; Satsutani N; Miyamoto R; Nomura S Int Immunol; 2013 Mar; 25(3):171-82. PubMed ID: 23125331 [TBL] [Abstract][Full Text] [Related]
4. T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease. Bergmann C; Strauss L; Wang Y; Szczepanski MJ; Lang S; Johnson JT; Whiteside TL Clin Cancer Res; 2008 Jun; 14(12):3706-15. PubMed ID: 18559587 [TBL] [Abstract][Full Text] [Related]
5. Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer. Zhou G; Noordam L; Sprengers D; Doukas M; Boor PPC; van Beek AA; Erkens R; Mancham S; Grünhagen D; Menon AG; Lange JF; Burger PJWA; Brandt A; Galjart B; Verhoef C; Kwekkeboom J; Bruno MJ Oncoimmunology; 2018; 7(7):e1448332. PubMed ID: 29900067 [No Abstract] [Full Text] [Related]
6. ICOS Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099 [TBL] [Abstract][Full Text] [Related]
7. Increased Frequency of CD49b/LAG-3(+) Type 1 Regulatory T Cells in HIV-Infected Individuals. Koch K; Koch N; Sandaradura de Silva U; Jung N; Schulze zur Wiesch J; Fätkenheuer G; Hartmann P; Romerio F; Lehmann C AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1238-46. PubMed ID: 26192268 [TBL] [Abstract][Full Text] [Related]
8. Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer. Pedroza-Gonzalez A; Verhoef C; Ijzermans JN; Peppelenbosch MP; Kwekkeboom J; Verheij J; Janssen HL; Sprengers D Hepatology; 2013 Jan; 57(1):183-94. PubMed ID: 22911397 [TBL] [Abstract][Full Text] [Related]
9. ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4 Faget J; Sisirak V; Blay JY; Caux C; Bendriss-Vermare N; Ménétrier-Caux C Oncoimmunology; 2013 Mar; 2(3):e23185. PubMed ID: 23802069 [TBL] [Abstract][Full Text] [Related]
10. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity. Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902 [TBL] [Abstract][Full Text] [Related]
11. The effect of immune microenvironment on the progression and prognosis of colorectal cancer. Chen J; Chen Z Med Oncol; 2014 Aug; 31(8):82. PubMed ID: 25034363 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 inhibits Tr1 cell differentiation through suppression of c-Maf. Hooper KM; Kong W; Ganea D PLoS One; 2017; 12(6):e0179184. PubMed ID: 28604806 [TBL] [Abstract][Full Text] [Related]
13. Disruption of the Notch pathway aggravates airway inflammation by inhibiting regulatory T cell differentiation via regulation of plasmacytoid dendritic cells. Qu SY; Ti XY; Zhang J; Wu CG Scand J Immunol; 2020 May; 91(5):e12865. PubMed ID: 32185817 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation. Wan J; Huang F; Hao S; Hu W; Liu C; Zhang W; Deng X; Chen L; Ma L; Tao R Cell Physiol Biochem; 2017; 43(1):353-366. PubMed ID: 28869950 [TBL] [Abstract][Full Text] [Related]
15. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells. Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134 [TBL] [Abstract][Full Text] [Related]
16. Tr1-Like T Cells - An Enigmatic Regulatory T Cell Lineage. White AM; Wraith DC Front Immunol; 2016; 7():355. PubMed ID: 27683580 [TBL] [Abstract][Full Text] [Related]
17. Determination of Tr1 cell populations correlating with distinct activation states in acute IAV infection. Abbott CA; Freimayer EL; Tyllis TS; Norton TS; Alsharifi M; Heng AHS; Pederson SM; Qu Z; Armstrong M; Hill GR; McColl SR; Comerford I Mucosal Immunol; 2023 Oct; 16(5):606-623. PubMed ID: 37321403 [TBL] [Abstract][Full Text] [Related]
18. GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cells Pedroza-Gonzalez A; Zhou G; Singh SP; Boor PP; Pan Q; Grunhagen D; de Jonge J; Tran TK; Verhoef C; IJzermans JN; Janssen H; Biermann K; Kwekkeboom J; Sprengers D Oncoimmunology; 2015 Dec; 4(12):e1051297. PubMed ID: 26587321 [TBL] [Abstract][Full Text] [Related]
19. Primary Tr1 cells from metastatic melanoma eliminate tumor-promoting macrophages through granzyme B- and perforin-dependent mechanisms. Yan H; Zhang P; Kong X; Hou X; Zhao L; Li T; Yuan X; Fu H Tumour Biol; 2017 Apr; 39(4):1010428317697554. PubMed ID: 28378637 [TBL] [Abstract][Full Text] [Related]
20. Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node. Gai XD; Song Y; Li C; Lei YM; Yang B Pathol Res Pract; 2013 Dec; 209(12):774-8. PubMed ID: 24080284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]